Reducing IOP in POAG patients

Article

Dr Willoughby discusses his experiences with the iStent

It has been shown in previous research that there is increased outflow resistance and as such reduced outflow facility in the trabecular meshwork in primary open-angle glaucoma patients.1 A potential treatment to increase the outflow facility is implantation of a trabecular microbypass stent. In his research, Dr Colin Willoughby (Belfast Health and Social Care Trust and Cathedral Eye Clinic, Belfast, Northern Ireland) looked at a treatment that would provide an effective solution for POAG patients with uncontrolled intraocular pressure (IOP) despite maximal medical treatment with evidence of progressive disease, particularly if combined with phacoemulisification.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
3 experts are featured in this series.
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.